Celebrating Rosacea Awareness Month 2025 with Dermatology Times

April is Rosacea Awareness Month, a period of time dedicated to raising awareness about the chronic skin condition that affects approximately 16 million Americans and 45 million worldwide, according to the National Rosacea Society.¹ Through initiatives like Rosacea Awareness Month, the dermatology community aims to shed light on the condition's complexities, reduce stigma, and empower individuals to seek appropriate care

Dermatology Times invites you to join us in advancing understanding, promoting dialogue, and ultimately improving outcomes for individuals living with rosacea, not just this month but all year round. From emerging therapies and new products to treatment gaps and future goals, below is a collection of pieces from this month dedicated to rosacea management.

Oxymetazoline 1% Cream Reduces Erythema in Patients with Rosacea

Oxymetazoline 1% cream was tested for mild to moderate rosacea-associated erythema on the face. After 4 weeks, the topical effectively decreased redness, stratum corneum hydration, telangiectasia, and vessel diameter in patients with darker skin tones. Oxymetazoline hydrochloride is an α1A adrenoceptor agonist that was approved by the US Food and Drug Administration in 2017.

Continue Reading

Choosing the Correct Skin Care for Rosacea with skinbetter science and Zoe Diana Draelos, MD

“Everybody needs to wash their face, use a moisturizer, and use sunscreen,” Zoe Diana Draelos, MD, said, “But because people with rosacea have sensitive skin, they need to be more judicious in their selection of skincare products.”

In a recent interview to celebrate April’s Rosacea Awareness Month, Draelos, consulting professor at Duke University School of Medicine, founder of Dermatology Consulting Services, PLLC, and Dermatology Times’ editor in chief emeritus, discussed the significance of this month.

Continue Reading

Rosacea: Progress, Challenges, and the Road Ahead

“We haven’t even gotten close to the kind of genetic phenotyping we see in psoriasis and atopic dermatitis. There is still a lot to learn,” said James Del Rosso, DO, in a recent interview with Dermatology Times on the state of rosacea research. While the exact cause of rosacea remains elusive, advancements in research have significantly improved our understanding of the disease, leading to better management strategies. Experts such as Del Rosso and Zoe Diana Draelos, MD, have contributed extensively to this field, offering insights into emerging therapies, treatment gaps, and the evolving perspective on rosacea pathophysiology.

Continue Reading our April Cover Story

Compound Heparin Sodium Allantoin Gel Can Treat Rosacea and Improve Skin Barrier

A new study found that topical compound heparin sodium allantoin gel is effective and safe for papulopustular rosacea treatment. After 12 weeks of therapy, patients saw improvements in hydration, transepidermal water loss, erythema, itching, burning, and quality of life.

Continue Reading

Treating Rosacea and Other Concerns with Generative Skin’s Ingredient Library

In her latest venture, Anastasia Georgievskaya, CEO and co-founder of Haut.AI, introduces Generative Skin, an interactive digital platform powered by SkinGPT that aims to revolutionize how patients understand skincare ingredients and their effects. This new initiative combines clinical accuracy with unique artificial intelligence simulations, allowing patients to visualize how specific ingredients may impact their skin and address their concerns, including rosacea.

Continue Reading

Understanding the Role of the Microbiome in Rosacea

Creating public awareness about rosacea is essential for medical providers, especially in understanding the psychosocial impact it can have on individuals. Clinicians play a crucial and empowering role in educating patients, particularly those newly diagnosed, about their condition and how to manage it effectively. This proactive approach can prevent the condition from worsening, saving the patient both frustration and the financial burden of managing the condition. The clinician's commitment to patient education is key, as it is in all skin diseases, and should address all aspects during the patient visit, including the role of the microbiome in rosacea.

Continue Reading from Renata Block, MMS, PA-C

Minocycline Foam Significantly Improves Papulopustular Rosacea Outcomes

Topical minocycline foam significantly reduced inflammatory skin lesions and improved Investigator Global Assessment (IGA) scores among patients with papulopustular rosacea (PPR), according to data published in Frontiers in Medicine.

Continue Reading

Hyaluronic Acid Boosts Results in Rosacea Management

Despite its prevalence, rosacea's impact on patients' quality of life is frequently underestimated. The visible nature of its symptoms can lead to significant psychosocial distress, including low self-esteem and social withdrawal.

Continue Reading

Reference

1. Keesecker N. Rosacea Awareness Month Calls for Holistic Approach. National Rosacea Society. April 1, 2025. Accessed April 30, 2025. https://www.rosacea.org/blog/2025/april/rosacea-awareness-month-calls-for-holistic-approach